Insider Transactions in Q4 2025 at Essa Pharma Inc. (EPIX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 09
2025
|
David Ross Parkinson President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65,675
-100.0%
|
-
|
|
Oct 09
2025
|
Richard M Glickman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,240
-100.0%
|
-
|
|
Oct 09
2025
|
Franklin M Berger Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
784,404
-100.0%
|
-
|
|
Oct 09
2025
|
David S. Wood Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,343
-100.0%
|
-
|
|
Oct 09
2025
|
Marella Thorell Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,881
-100.0%
|
-
|
|
Oct 09
2025
|
John Alexander Martin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,299
-100.0%
|
-
|
|
Oct 09
2025
|
Scott Requadt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,002
-100.0%
|
-
|
|
Oct 09
2025
|
Bvf Partners L P > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,481,685
-100.0%
|
-
|